AI Vital For Rapid Identification of Drugs That Can Be Repurposed To Combat COVID-19, Says New Report
Artificial intelligence (AI) offers significant promise for biopharmaceutical companies to speed up the drug repurposing process for finding new therapies to treat COVID-19, according to a new report. More...21 Aug 2020
Leica Biosystems Partners with Bio-Techne for Automation of RNAscope COVID-19 Probes on BOND RX Staining Platform
Leica Biosystems (Wetzlar, Germany) and Bio-Techne Corporation (Minneapolis, MN, USA) have entered into a partnership for the automation of RNAscope COVID-19 probes on BOND RX, Leica's staining platform, for research use only. More...20 Aug 2020
New Research Collaboration to Develop Combination of Monoclonal Antibody and Natural Killer Cells as Treatment for COVID-19
A new research collaboration will focus on the development of a combination of a monoclonal antibody (mAb) and Natural Killer (NK) cells as a treatment for COVID-19. More...20 Aug 2020
J&J’s Janssen Partners with BioSymetrics for Predicting Onset and Severity of COVID-19 Using Machine Learning
Johnson & Johnson’s (New Brunswick, NJ, USA) Janssen Pharmaceuticals Inc. (Beerse, Belgium) has entered into a collaboration with BioSymetrics Inc. (New York, NY, USA) and Sema4 (Stamford, CT, USA) that will focus on predicting the onset and severity of COVID-19 among different populations using machine learning. More...20 Aug 2020
COVID-19 Medical Imaging Center Enables AI-Driven Research to Better Understand SARS-CoV-2 Effect on Human Body
A new center hosted at the University of Chicago (Chicago, IL, USA) and co-led by the largest medical imaging professional organizations in the US will help tackle the ongoing COVID-19 pandemic by curating a massive database of medical images to help better understand and treat the disease. More...20 Aug 2020
Clinical Trial to Test Cystic Fibrosis Drug in Patients with Severe COVID-19 Pneumonia and Respiratory Failure
Harvard Medical School (Boston, MA, USA) researchers at Boston Children’s Hospital and Brigham and Women’s Hospital have begun testing an existing drug, dornase alfa, in patients with severe COVID-19 pneumonia and respiratory failure. More...20 Aug 2020
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
LED Surgical Light
Convelar 1670 LED+/1675 LED+/1677 LED+
New
Cannulating Sphincterotome
TRUEtome
In Other News
Engineered Decoy ACE2 Receptors That Neutralize Coronavirus and Block Infection Could Directly Treat COVID-19
New Lab-Based Studies Show Two Existing Drugs Inhibit SARS-CoV-2 from Infecting Human Cells
Drug Candidate Significantly Outperforms Gilead’s Remdesivir Head-to-Head in SARS-CoV-2 (COVID-19) Model
New Diagnostic Test for Heart Failure Patients Could Lead To Diagnostics and Treatments for COVID-19
10-Minute POC COVID-19 Test Accurately Detects SARS-CoV-2 3C-Protease in Saliva Samples
FDA-Approved Drug to Treat Rare Diseases of Overactive Immune System Could Help Critically Ill COVID-19 Patients
Scientists Developing Coronavirus Strain To Deliberately Infect Volunteers in Human Challenge Trials of COVID-19 Vaccine
Beckman Coulter and Thermo Fisher to Help HHS Expand US Diagnostic Labs’ COVID-19 Testing Capacity
ELITech Group Distributes More Than 3.5 Million COVID-19 Tests and Installs Over 500 PCR Systems Globally
PerkinElmer Launches Explorer Series Workstations for High-Throughput SARS-CoV-2 Testing With 10,000 COVID-19 Tests Capacity per Day
Large-Scale Genetic Screening Could Identify Populations Vulnerable To COVID-19
Identification of Protein That Helps Coronavirus Spread through Cells Could Help Develop COVID-19 Treatment
Drug Used To Treat Bipolar Disorder and Hearing Loss Stops Coronavirus from Replicating In Host Cells
Wearable AI Device Monitors Key Biometrics of Volunteers in World's First Phase 3 Trials Of Inactivated COVID-19 Vaccine
Russia’s Sputnik V COVID-19 Vaccine Begins Global Phase 3 Trials
AI Spectral Technology COVID-19 Detection Test Achieves 95% Success Rate in Clinical Trial
Molecular Engineers Adopt Innovative Approaches to COVID-19 Vaccine
New Low-cost COVID-19 Test Detects Coronavirus in 20 Minutes
Molecular Engineers Adopt Innovative Approaches to COVID-19 Vaccine
Ground-Breaking One-Step COVID-19 Cartridge May Enable Large-Scale Antibody Testing
LumiraDx's SARS-CoV-2 RNA STAR Assay Secures FDA Emergency Use Authorization
New Nasal Swab Robot to Help Expand Testing For SARS-CoV-2 Virus
Identification of Possible Mechanism for Blood Clots in COVID-19 Patients May Help Develop More Effective Treatments
